The largest database of trusted experimental protocols

Anti cd8 yts169.4

Manufactured by BioXCell

Anti-CD8 (YTS169.4) is a monoclonal antibody that recognizes the CD8 co-receptor on T cells. It is a useful tool for the identification and isolation of CD8+ T cells.

Automatically generated - may contain errors

2 protocols using anti cd8 yts169.4

1

Murine K-RasG12Dp53null Lung Adenocarcinoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
The murine K-RasG12Dp53null lung adenocarcinoma was isolated from lung tumors of the K-RasG12Dp53null transgenic mice obtained from J. Kurie (MD Anderson Houston, TX, USA). The culture medium (CM) was RPMI 1640 supplemented with 10% fetal bovine serum (Gemini Bioproducts West Sacramento, CA, USA), 100 units/mL penicillin, 0.1 mg/mL streptomycin, and 2 mM glutamine (JRH Biosciences Lenex, MA, USA). Fluorescein isothiocyanate-, phycoerythrin-, allophycocyanin-, PerCP-, or APC-Cy7-conjugated anti-mouse Abs to CD4 (RM4-5) and CD8a (53-6.7) were from BD Biosciences or eBiosciences. For in vivo experiments, anti-PD-1 (BE0146), anti-CD4 (L3T4), and anti-CD8 (YTS169.4) were from BioXCell. Isotype control antibody (Ab) was from Sigma. The Abs used for T cell depletion were different for monitoring T cell levels. Bradford protein quantification dye was obtained from Sigma. Tissue digestion buffer was obtained from Miltenyi and used in Miltenyi tissue homogenizer according to the manufacturer’s instructions. T cell purification columns were from R&D.
+ Open protocol
+ Expand
2

Murine Tumor Inoculation and Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
5×104 B16F1 (or 3×105 when indicated) or 5×105 CT-26 or BRAFCAPten−/− cells diluted in sterile PBS1X were injected subcutaneously into the shaved flank of each mouse. For metastasis experiments, 2.5×104 B16F10 cells were injected intravenously in the tail vein. PTXF (Sigma) was diluted in PBS1X and sterile filtered prior to each injection. IT-603 (Calbiochem) was first diluted in EtOH for storage; prior to injections it was further diluted in Cremophor EL and then in warm PBS1X (for a final ratio of 1 EtOH: 1 Cremophor:4 PBS1X). Anti-PD-1 (RMP1-14), anti-PD-L1 (10F.9G2) and anti-CD8 (YTS.169-4) mAbs were obtained from BioXCell. Rat IgG isotype control was from R&D Systems. Mice received intraperitoneal injections of 50mg/kg PTXF, 200 μg IT-603 or 200 μg of the given mAb. In Figure 5, BALB/c mice harboring CT-26 tumors received a suboptimal dose of 100 μg of anti-PD-1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!